ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Teva settles California’s pay-for-delay allegations pharmaceutical-technology
August 01, 2019Drug companies Teva Pharmaceutical, Endo Pharmaceuticals and Teikoku Pharma have signed four settlement agreements with the State of California to resolve allegations regarding pay-for-delay deals to prevent cheaper, generic medicines from entering the ma -
Mylan Agrees to Pay $465 Million for Underpaying EpiPen Rebates
americanpharmaceuticalreview
August 21, 2017Mylan Inc. and Mylan Specialty L.P. have agreed to pay $465 million to resolve claims that they violated the False Claims Act by knowingly misclassifying EpiPen?as a generic drug to avoid paying rebates owed primarily to Medicaid, the Justice Department a
Pharma Sources Insight January 2025
